ADMA Biologics ADMA Medford settlement proceeds (Note A)
Medford settlement proceeds (Note A) at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromInsuranceSettlementOperatingActivities.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's medford settlement proceeds (note a).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's medford settlement proceeds (note a)?
- ADMA Biologics (ADMA) reported medford settlement proceeds (note a) of $400K in Q1 2025.
- What does medford settlement proceeds (note a) mean?
- Cash received from insurance providers as a result of claims related to operational losses, legal disputes, or property damage. These proceeds represent non-recurring inflows that offset previous losses and impact net cash flow from operations.